• Bedfont Scientific acquired coVita, its exclusive U.S. distributor, in a deal backed by Keensight Capital.
• Transaction brings Bedfont closer to U.S. healthcare networks and clinical research, with a focus on its NObreath FeNO device.
• coVita is based in The Woodlands, Texas, distributing Bedfont products for more than 16 years.
• coVita’s founders, Jason Aversano and Daniel Sibis, will remain involved to support continuity with customers and partners.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Keensight Capital SAS published the original content used to generate this news brief on October 13, 2026, and is solely responsible for the information contained therein.